In-cell generation of antibody single-chain Fv transcripts by targeted RNA trans-splicing

Journal of Immunological Methods

Volumn 282, Issue 1-2, 2003, Pages 175-186

  Schlesinger, Jacob ^a,b   Arama, Dina ^a   Noy, Hava ^a   Dagash, Manar ^a   Belinky, Paula ^a   Gross, Gideon ^a,c  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL HAI COLLEGE   (Israel)

Author keywords

Monoclonal antibodies; RNA trans splicing; Variable region genes

Indexed keywords

RNA; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL CELL; ANTIBODY ISOLATION; ARTICLE; B LYMPHOCYTE; CELL LINE; CELL STRAIN COS7; CONTROLLED STUDY; DONOR SITE; EXON; EXPERIMENTAL MODEL; GENE DELETION; GENE LOCATION; GENE TARGETING; GENETIC CODE; GENETIC LINKAGE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HYBRIDOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SYNTHESIS; SEQUENTIAL ANALYSIS; TRANS SPLICING;

EID: 0242321277     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2003.08.006     Document Type: Article

References (36)

1. Carmo-Fonseca M., Custodio N., Calado A. Intranuclear trafficking of messenger RNA. Crit. Rev. Eukaryot. Gene Expr. 9:1999;213-219.
2. Chen-Bettecken U., Wecker E., Schimpl A. Transcriptional control of mu- and kappa-gene expression in resting and bacterial lipopolysaccharide-activated normal B cells. Immunobiology. 174:1987;162-176.
3. Codony C., Guil S., Caudevilla C., Serra D., Asins G., Graessmann A., Hegardt F.G., Bach-Elias M. Modulation in vitro of H-ras oncogene expression by trans-splicing. Oncogene. 20:2001;3683-3694.
4. Cook G.P., Tomlinson I.M., Walter G., Riethman H., Carter N.P., Buluwela L., Winter G., Rabbitts T.H. A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat. Genet. 7:1994;162-168.
5. Dallinger G., Puttaraju M., Mitchell L.G., Yancey K.B., Hintner H., Bauer J.W. Collagen 17A1 gene correction using spliceosome mediated RNA trans-splicing (SMaRT trade mark) technology. J. Invest. Dermatol. 115:2000;332.
6. Dallinger G., Puttaraju M., Mitchell L.G., Yancey K.B., Yee C., Klausegger A., Hintner H., Bauer J.W. Development of spliceosome-mediated RNA trans-splicing (SMaRT trade mark) for the correction of inherited skin diseases. Exp. Dermatol. 12:2003;37-46.
7. Embleton M.J., Gorochov G., Jones P.T., Winter G. In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells. Nucleic Acids Res. 20:1992;3831-3837.
8. Fujieda S., Lin Y.Q., Saxon A., Zhang K. Multiple types of chimeric germ-line Ig heavy chain transcripts in human B cells: evidence for trans-splicing of human Ig RNA. J. Immunol. 157:1996;3450-3459.
9. Han H., Okamoto M., Honjo T., Shimizu A. Regulated expression of immunoglobulin trans-mRNA consisting of the variable region of a transgenic mu chain and constant regions of endogenous isotypes. Int. Immunol. 3:1991;1197-1206.
10. Jones J.T., Sullenger B.A. Evaluating and enhancing ribozyme reaction efficiency in mammalian cells. Nat. Biotechnol. 15:1997;902-905.
11. Jones J.T., Lee S.W., Sullenger B.A. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nat. Med. 2:1996;643-648.
12. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
13. Kohler G., Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur. J. Immunol. 6:1976;511-519.
14. Konarska M.M., Padgett R.A., Sharp P.A. Trans splicing of mRNA precursors in vitro. Cell. 42:1985;165-171.
15. Lam B.J., Hertel K.J. A general role for splicing enhancers in exon definition. RNA. 8:2002;1233-1241.
16. Lin A.Y., Devaux B., Green A., Sagerstrom C., Elliott J.F., Davis M.M. Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science. 249:1990;677-679.
17. Liu X., Jiang Q., Mansfield S.G., Puttaraju M., Zhang Y., Zhou W., Cohn J.A., Garcia-Blanco M.A., Mitchell L.G., Engelhardt J.F. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat. Biotechnol. 20:2002;47-52.
18. Mansfield S.G., Kole J., Puttaraju M., Yang C.C., Garcia-Blanco M.A., Cohn J.A., Mitchell L.G. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing. Gene Ther. 7:2000;1885-1895.
19. Matsuda F., Ishii K., Bourvagnet P., Kuma K., Hayashida H., Miyata T., Honjo T. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J. Exp. Med. 188:1998;2151-2162.
20. Nilsen T.W. Trans-splicing: an update. Mol. Biochem. Parasitol. 73:1995;1-6.
21. Nolan-Willard M., Berton M.T., Tucker P. Coexpression of mu and gamma 1 heavy chains can occur by a discontinuous transcription mechanism from the same unrearranged chromosome. Proc. Natl. Acad. Sci. U. S. A. 89:1992;1234-1238.
22. Ochi A., Hawley R.G., Shulman M.J., Hozumi N. Transfer of a cloned immunoglobulin light-chain gene to mutant hybridoma cells restores specific antibody production. Nature. 302:1983;340-342.
23. Parreira L., Telhada M., Ramos C., Hernandez R., Neves H., Carmo-Fonseca M. The spatial distribution of human immunoglobulin genes within the nucleus: evidence for gene topography independent of cell type and transcriptional activity. Hum. Genet. 100:1997;588-594.
24. Phylactou L.A., Darrah C., Wood M.J. Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nat. Genet. 18:1998;378-381.
25. Puttaraju M., Jamison S.F., Mansfield S.G., Garcia-Blanco M.A., Mitchell L.G. Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat. Biotechnol. 17:1999;246-252.
26. Puttaraju M., DiPasquale J., Baker C.C., Mitchell L.G., Garcia-Blanco M.A. Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing. Molec. Ther. 4:2001;105-114.
27. Shimizu A., Honjo T. Synthesis and regulation of trans-mRNA encoding the immunoglobulin epsilon heavy chain. FASEB J. 7:1993;149-154.
28. Shimizu A., Nussenzweig M.C., Mizuta T.R., Leder P., Honjo T. Immunoglobulin double-isotype expression by trans-mRNA in a human immunoglobulin transgenic mouse. Proc. Natl. Acad. Sci. U. S. A. 86:1989;8020-8023.
29. Shimizu A., Nussenzweig M.C., Han H., Sanchez M., Honjo T. Trans-splicing as a possible molecular mechanism for the multiple isotype expression of the immunoglobulin gene. J. Exp. Med. 173:1991;1385-1393.
30. Solnick D. Trans splicing of mRNA precursors. Cell. 42:1985;157-164.
31. Stevens R.H., Askonas B.A., Welstead J.L. Immunoglobulin heavy chain mRNA in mitogen-stimulated B cells. Eur. J. Immunol. 5:1975;47-53.
32. Sullenger B.A., Cech T.R. Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing. Nature. 371:1994;619-622.
33. Tomlinson I.M., Walter G., Marks J.D., Llewelyn M.B., Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J. Mol. Biol. 227:1992;776-798.
34. Watanabe T., Sullenger B.A. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8490-8494.
35. Whitlow M., Bell B.A., Feng S.L., Filpula D., Hardman K.D., Hubert S.L., Rollence M.L., Wood J.F., Schott M.E., Milenic D.E.et al. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. Protein Eng. 6:1993;989-995.
36. Zhang K., Diaz-Sanchez D., Saxon A. Germ-line human epsilon heavy chain gene RNA transcripts utilize the full range of alternative 3′ splicing seen in productive epsilon mRNA. Immunology. 85:1995;228-235.